Trial Profile
Predictive Parameters for Therapeutic Efficacy of Initial Combination Therapy With Sitagliptin and Metformin in Type 2 Diabetic Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms COSMETIC
- 05 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2011 Planned end date changed from May 2011 to Jul 2011 as reported by ClinicalTrials.gov.
- 23 May 2011 Planned end date changed from 1 Dec 2010 to 1 May 2011 as reported by ClinicalTrials.gov.